Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06180837 · ClinicalTrials.gov registry record · NA
Effect of Sleep Extension on Ceramides in People with Overweight and Obesity
A NA study of Type 2 Diabetes and Sleep, sponsored by University of Utah.
- Recruiting
- Registry status
- NA
- Development phase
- 70
- Enrollment target
- 1
- Study location
NCT06180837: Recruiting NA study of Type 2 Diabetes and Sleep, sponsored by University of Utah.
NCT06180837 is a NA study of Type 2 Diabetes and Sleep that is actively recruiting participants, run by University of Utah. The registered enrollment target is 70 participants, below the 3,923-participant average among 327 other Type 2 Diabetes trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06180837, a NA study of Type 2 Diabetes and Sleep, is actively recruiting participants, sponsored by University of Utah.
- RECRUITING
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall goal is to determine how a sleep extension intervention (increasing time in bed) in individuals who maintain less than 6.5 hours sleep per night affects their plasma ceramides and insulin sensitivity. Participants will undergo a randomized controlled trial, with sleep extension (intervention) and healthy lifestyle (control) groups. The sleep extension is designed to increase participant's time in bed by 2 hours per night. Alternatively, the control group will receive basic health information (e.g., physical activity, goal setting, and nutrition when eating out).
Primary Outcome
Total plasma ceramides will be measured by assessing plasma ceramides by targeted metabolomics.
Conditions Studied
Interventions
- BEHAVIORAL Sleep Extension Intervention
Study Locations (1)
Utah
- College of Health Research Complex--University of Utah - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2024-02-12 |
| Est. Completion | 2028-01 |
| Phase | NA |
What NCT06180837 shows while recruiting
NCT06180837 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 3,923-participant average among 327 other Type 2 Diabetes trials with a reported enrollment target (98% lower).
The record links to 9 conditions, with Type 2 Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Sleep Extension Intervention is the first listed.
NCT06180837 reports a single indexed study location in Utah.
Frequently Asked Questions
What is clinical trial NCT06180837 about?
NCT06180837 is a clinical study titled "Effect of Sleep Extension on Ceramides in People with Overweight and Obesity". The overall goal is to determine how a sleep extension intervention (increasing time in bed) in individuals who maintain less than 6.5 hours sleep per night affects their plasma ceramides and insulin sensitivity. Participants will undergo a randomized controlled trial, with sleep extension (interven...
What is the current status of trial NCT06180837?
This trial is currently recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2024-02-12. Estimated completion is 2028-01.
What conditions does trial NCT06180837 study?
This clinical trial studies the following conditions: Type 2 Diabetes, Sleep, Overweight and Obesity, Sleep Deprivation, Insulin Sensitivity.
What interventions are being tested in trial NCT06180837?
The interventions under investigation include: Sleep Extension Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT06180837?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06180837 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 2 Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06180837's enrollment target sits among peer trials
70 184th of 327 higher than 141 of 327 other Type 2 Diabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Type 2 Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Enhancing Telemedicine for T2D
RECRUITING · NA
-
Sleep and Glycemic Control in Type 2 Diabetes Adolescents
RECRUITING · NA
-
Enhancing Preventative Health Behaviors Among Emergency Department Hyperglycemic Patients
RECRUITING · NA
-
Ultrasound Effects on Glycemic Control in T2DM
RECRUITING · NA
-
A Randomized Double-Blinded and Placebo-Controlled Trial to Assess the Efficacy of Biophoton Therapy to Treat Type 2 Diabetes
RECRUITING · NA
-
High Fructose Diet, the Gut Microbiome, and Metabolic Health
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI